Category | Insight journal

NPS Pharmaceuticals: Big biotech partnering trends 2009-2014

Posted on 21 August 2014

NPS Pharmaceuticals is a US based specialty company. The company mainly focuses its efforts to treat rare diseases worldwide. 

Tags: ,

Cubist Pharma, the next acquisition target for big pharmaceuticals

Posted on 19 August 2014

The timing may be right for a takeover of Cubist Pharmaceuticals.

Tags: , ,

SciClone Pharmaceuticals: Your marketing partner for China

Posted on 18 August 2014

Sciclone Pharmaceuticals is a specialty pharmaceutical company focused on developing and marketing products to treat oncology, infectious diseases and urology.

Tags: , ,

Roche to buy 40% stake in Chugai Pharma

Posted on 18 August 2014

Roche Holding is in talks to buy the almost 40 percent of Chugai Pharmaceutical that it doesn’t already own to gain full control of its Japanese partner for oncology and arthritis drugs, according to people familiar with the matter.

Tags: ,

Current Agreements Deal Analysis Update : August 2014

Posted on 15 August 2014

This month we provide you with a deal analysis  overview of life science partnering, M&A and financing in July 2014.

Tags: , , ,

InterMune looking for oppurtunities for buyout

Posted on 15 August 2014

Multiple sources are reporting that biotechnology company, InterMune, Inc. (ITMN), is officially preparing for a buyout.

Tags: ,

Life Science M&A Deal Trends in Q2, 2014

Posted on 14 August 2014

By Steve Poile                                     With 110 deals announced, the second quarter continued on from the strong start for life science M&A during 2014.

Tags: ,

Bavarian Nordic: Biotechnology partnering activity 2009-2014

Posted on 11 August 2014

Bavarian Nordic is an international biotechnology headquartered in Denmark.

Tags: , , ,

NPS Pharmaceuticals – developing and partnering for rare diseases

Posted on 10 August 2014

NPS Pharmaceuticals is a global pharmaceutical company treating rare diseases specifically focusing upon gastrointestinal and endocrine disorders.

Tags: ,

SciClone Pharmaceuticals: Big biotech partnering trends 2009-2014

Posted on 08 August 2014

SciClone Pharmaceuticals is a US based specialty company. The company focusses its efforts to widen its portfolio in China by in-licensing and acquiring rights to marketed products.

Tags: , ,

cpbannerad300x150new3gif
nlsd2014jpg
current-partnering-300x150-orphanjpg
RSS Feed Linked In Twitter

Latest Tweets

cpbannerad300x150new1gif
e56300x150animgif
ddp-banner-for-current-partgif